286 related articles for article (PubMed ID: 17320974)
1. Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy patients in Hyderabad, India.
Andersson AK; Atkinson SE; Khanolkar-Young S; Chaduvula M; Jain S; Suneetha L; Suneetha S; Lockwood DN
Immunol Lett; 2007 Mar; 109(1):72-5. PubMed ID: 17320974
[TBL] [Abstract][Full Text] [Related]
2. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy.
Chaitanya VS; Lavania M; Nigam A; Turankar RP; Singh I; Horo I; Sengupta U; Jadhav RS
Immunol Lett; 2013; 156(1-2):159-67. PubMed ID: 24189521
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
Stegk JP; Ebert B; Martin HJ; Maser E
Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
[TBL] [Abstract][Full Text] [Related]
4. Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.
Struwe E; Berzl GM; Schild RL; Beckmann MW; Dörr HG; Rascher W; Dötsch J
Am J Obstet Gynecol; 2007 Jul; 197(1):43.e1-6. PubMed ID: 17618751
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
[TBL] [Abstract][Full Text] [Related]
6. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
Seckl JR
Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
[TBL] [Abstract][Full Text] [Related]
7. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?
Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Jun; 52(6):1711-20. PubMed ID: 15934114
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
[TBL] [Abstract][Full Text] [Related]
9. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
Draper N; Stewart PM
J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis.
Claus R; Wagner A; Lambert T
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111
[TBL] [Abstract][Full Text] [Related]
11. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
Terao M; Itoi S; Murota H; Katayama I
Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
[TBL] [Abstract][Full Text] [Related]
13. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells.
Tsugita M; Iwasaki Y; Nishiyama M; Taguchi T; Shinahara M; Taniguchi Y; Kambayashi M; Terada Y; Hashimoto K
Life Sci; 2008 Sep; 83(11-12):426-32. PubMed ID: 18692075
[TBL] [Abstract][Full Text] [Related]
15. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
[TBL] [Abstract][Full Text] [Related]
16. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
[TBL] [Abstract][Full Text] [Related]
17. 11beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.
Causevic M; Mohaupt M
Mol Aspects Med; 2007 Apr; 28(2):220-6. PubMed ID: 17532462
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
[TBL] [Abstract][Full Text] [Related]
19. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
[TBL] [Abstract][Full Text] [Related]
20. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
